Diagnostics
New research shows a clear association between brain tumour size and mortality, with earlier diagnosis linked to improved survival outcomes. The findings suggest that detecting brain cancer just one month earlier could reduce annual mortality risk by 18–28 per cent. Clinical-stage diagnostics company Dxcover Limited analysed records from 1,196 patients to evaluate how tumour size [...]
Patients could soon benefit from world-leading technology to diagnose bowel cancer earlier, faster and cheaper, reducing the need for invasive colonoscopies and biopsies, and potentially saving valuable time and resource for the NHS, the UK government has announced today. The technology has the potential to detect bowel cancer earlier, improving diagnosis rates, and offering patients [...]
A new study has found that 9 per cent of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75 per cent were associated with only three genes that impact how the body [...]
Hodd Barnes Dickins, a leading independent optician based in Holborn, is the first clinic in the UK to expand eye exams into a gateway for cardiovascular health with Dr.Noon CVD—an AI-powered retinal screening technology that assesses potential cardiovascular disease (CVD) risk. Traditionally, opticians have played a role in detecting cardiovascular risks by identifying retinal signs [...]
Diagnostics company Dxcover has raised US$6m to accelerate its multiomic spectral analysis - MOSA-Dx - for the early detection of solid tumour cancers, with backing from Macmillan Cancer Support and Maven Capital Partners. By combining machine learning, light and technical innovation, Dxcover’s multi-omic spectral analysis technology analyses all molecules in the body related to cancer. [...]
A university spin-out which is pioneering the use of sweat sensors to address the health risks associated with climate change has raised US$26m to expand its global reach. Epicore Biosystems will use the funds to progress its personalised hydration and cloud analytics platform and expand into new biomarker targets relevant to malnutrition and environmental toxin [...]
Hundreds of potential kidney donors of Black African and Black Caribbean heritage can now get a simple blood test to help reduce the risk of kidney failure. The test is part of national genetic testing available on the NHS and will help identify if potential donors carry genes that mean they have a high risk [...]
A new one-minute video game can accurately and efficiently identify children with an autism diagnosis from those who have ADHD or are neurotypical. The game uses motion-tracking technology to detect differences in motor imitation skills. In a study, 183 children, ages seven to 13, were asked to copy the dance-like movements of a video avatar for one minute, [...]
A urine-based diagnostic kit for bladder cancer that can be conveniently used at home and can accurately detect bladder cancer biomarkers without any pre-processing of urine samples has been developed by researchers. Bladder cancer has a cure rate of over 90 per cent when detected early, but it has a high recurrence rate of 70 [...]
A prototype of a new oral cancer diagnosis device has demonstrated promising results during preliminary tests on histopathology specimens. The Liverpool Diagnostic Infrared Wand (LDIR Wand) is being developed by physicists at the University of Liverpool in collaboration with the Liverpool Head and Neck Centre (LHNC). Although still in the early stages of development and [...]
